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Objective: Prevention may improve the
quality of life and sexual and reproductive
health. To improve prevention require a comprehensive
research approach that examines the frequency and risk fac-
tors for urologic conditions. In June 2016 the Italian Urologic
Society coordinated a preventive initiative : the 1st Week of
Male Urologic Prevention ”#Controllati”. 
Material and methods: During the 1st Week of Male Urologic
Prevention “#Controllati”, men aged 18 years or more were
invited to attend participating urologic centers for a free of
charge visit for counseling about urologic or andrologic con-
ditions. Each participating man underwent a physical exami-
nation. Further he was asked about his a medical history and
about his urologic symptoms, sexual activity and possible
related problems. 
Results: Data were collected in 81 centers: 2380 men
answered the questionnaire. A total of 1226 subjects partici-
pating in the study reported one or more urinary symptom
[51.5% (IC 95% 48.9%-54.5%)]. The risk of any urinary
symptoms increased with age: in comparison with men aged
< = 30 years or less the risk of any urinary symptoms was
2.31, 2.92, 5.12, 7.82 and 17.02 respectively in the class age
31-40, 41-50, 51-60, 61-70 and > = 71. Overweight/obese
men were at increased risk of any urinary symptoms
[OR1.35 (95% CI 1.12-1.64)]. 27.2% (IC 95% overall 25.2%
-29.3%) of the subjects had at least a sexual disorder (erec-
tile dysfunction, premature ejaculation, hypoactive sexual
desire). The erectile dysfunction and hypoactive sexual desire
increased with age, but premature ejaculation tended to be
higher among younger aged men aged 40 years or more.
Current any urinary symptoms [OR 1.85 (CI 1.40-2.43)],
hypertension [OR 1.66 (95% CI 1.21-2.26) and diabetes 
(OR 2.37 (95% CI 1.45-3.88)] increased the risk of erectile
dysfunction.
Conclusions: This large survey gives a picture of the burden
of the more frequent urologic conditions offering useful infor-
mation in order to focus preventive campaign.
KEY WORDS: Risk factors; Urinary symptoms; Erectile dysfunc-
tion; Premature ejaculation.
Submitted 16 March 2017; Accepted 21 March 2017 
Summary
No conflict of interest declared.
DOI: 10.4081/aiua.2017.1.75
INTRODUCTION
Urologic diseases are common among men, leading to
significant economic, quality of life and public health
issues (1). For example, the reported prevalence of lower
urinary tract symptoms (LUTS) is about 50% (2) and of
erectile dysfunction 12% (3).
Among Italian men, the lifelong risk of urologic cancer
(prostatic bladder and kidney cancer) is about one out of
ten (4). The burden of urologic diseases in men will
increase as the population ages, and risk factors for
LUTS, including diabetes and obesity, remain highly
prevalent (5). Adequate prevention, especially in the
field of urology, made in young, adult and advanced age,
significantly reduces the frequency of cancer (prostate,
kidney, bladder and testicle), allowing also an early diag-
nosis and timely treatment, and benign disease (urolithi-
asis, benign prostate hyperplasia and prostatitis, male
infertility and sexual dysfunction), that can determine, if
neglected, a reduction in the quality of life, and sexual
and reproductive health damage.
Otherwise, to improve prevention requires a compre-
hensive research approach that examines the frequency
and risk factors for urologic conditions.
In June 2016 the Italian Urologic Society (SIU) coordinat-
ed a huge preventive initiative: the 1st Week of Male
Urologic Prevention “#Controllati”. In this paper, we pres-
ent the results of the initiative, with a special focus on
LUTS and sexual dysfunction.
METHODS
During the 1st Week of Male Urologic Prevention “#Control -
lati” (June 2016), men aged 18 years or more were invited
to attend participating urologic centers for a free of charge
visit for counselling about urologic or andrologic condi-
tions. A pamphlet inviting men for a free of charge
check-up and listing participating centers was left in
chemists and general practitioners’ waiting rooms and
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included in two weekly national journals; an advertising
campaign was set in the press and broadcast media. 
Each participating man underwent a physical examina-
tion. Further he was asked about his a medical history
and about his urologic symptoms, sexual activity and
possible related problems. Data were recorded with a
simple questionnaire used by all centers. 
The first section, about age, marital, educational and pro-
fessional status, weight, height, family history of prostatic
cancer was completed by the patient. History of hyperten-
sion, diabetes and other medical conditions, and the find-
ings of the clinical examination, were recorded by the
physician. Erectile function was assessed by asking men
about their sexual performance: erectile dysfunction (ED)
was diagnosed according to the definition of the NIH
Consensus Development Panel (6), when a man was consis-
tently unable to attain or maintain a penile erection suffi-
cient for satisfactory sexual performance. 
A man was diagnosed as suffering from premature ejac-
ulation (PE) if he had “persistent or recurrent ejaculation
with minima sexual stimulation before, or shortly after pene-
tration, and before the person wishes” according to the cat-
egorization of the American Psychiatric Association. 
Patients were directly asked about the presence of this
disorder during the visit. 
The 2002 ICS definitions were used for frequency, noc-
turia, urgency, dysuria (intermittency, slow stream,
straining, terminal dribble, postmicturition dribble)
incomplete emptying (7). A total of 181 centres partici-
pate to the initiative, 70  in the North, 45 in the center and
66 in the South of Italy. However, epidemiological data
were collected in 81 centers for a total of 2380 men who
filled the questionnaire [mean number for center 29 (SD
21), median 25 (interquartile range 24-40)].
Mean (standard deviation, SD), median (range) or fre-
quency (percent, %) were computed as appropriate.
Were also calculated where appropriate confidence lim-
its at 95% of the proportions.
Finally, we ran an analysis on the risk factors for sexual
dysfunction (separately for ED and PE) and urinary disor-
ders. Odds ratios (OR), and the corresponding 95% confi-
dence intervals (CI), were derived using unconditional
multiple logistic regression, fitted by the method of maxi-
mum likelihood, in which the dependent variable was the
presence (case) or absence (control) of the condition and
the independent ones were the exposures considered in the
analysis. We included in the model potential co-variates
considered as categorical variables (8). The terms included
in the model are indicated in the footnotes of the Tables.
RESULTS
The general characteristics of study subjects are shown in
Table 1: the mean age was 53.6 years (DS 11.5, median
age 53 years, range 18-87). The most frequent class age
was 41 to 50 years (31.09%).
The mean body mass index (BMI) was 26.0 (DS 3.6) and
the median 25.5. 
Most participants were ever married (70.1%). 
The 13.2% of subjects reported a diagnosis of hyperten-
sion and 3.7% of diabetes. A family history of prostatic
cancer was reported in 9.8% of subjects.
Frequency of PSA test screening and semen analysis
A total of 1291 men (54.2%, 95% CI 51.3% -57.3%) of
the study subjects reported PSA testing. Considering
subjects aged 70 years or more, this percentage increased
to 84.9% (95% CI 71.9% -99.5%).
Overall, 325 men reported a least one semen analysis in
life (13.7%, 95% CI 12.2-15.1%) (Table 2).
Frequency of and risk factors for urinary symptoms
A total of 1226 subjects participating in the study report-
ed one or more urinary symptom (51.5%, CI 95%
48.9%-54.5%). The most commonly reported urinary
symptom was nocturia, in age groups 50 or more,
whereas in younger age groups frequency was the most
reported (Table 3).
Table 1. 
Characteristics of study subjects.
N %
Age (years)
≤ 30 60 2.6
31-40 171 7.5
41-50 740 32,3
51-60 679 29.7
61-70 467 20.4
≥ 71 172 7.5
Marital status
Never married 497 22.6
Married 1668 75.8
Divorced/widower 36 1.6
BMI (kg/m2)
< 25.0 877 44.1
25.0 -29.9 886 44.6
≥ 30.0 225 11.3
Hystory of 
Hyperthension (yes) 314 13.2
Diabetes (yes) 87 3.7
Family history of prostatic cancer (yes) 232 9.8
Sometimes, the sums do not add up the total due to missing values
Table 2. 
Subjects reporting one or more PSA testing and semen
analysis in life in strata of age.
> = 1 PSA test in life > = 1 semen analysis in life
No* Yes No Yes
N % N % N % N %
Age (years)
≤ 30 58 2 52 8
(No. = 60) 96.7 3.3 86.7 13.3
31-40 158 13 138 33
(No. = 171) 92.4 7.6 80.7 19.3
41-50 508 232 605 135 
(No. = 740) 68.7 31.4 81.8 18.2
51-60 211 468 580 99
(No. = 679) 31.1 68.9 85.4 14.6
61-70 84 383 433 34
(No. = 467) 18.0 82.0 92.7 7.3
≥ 71 26 146 164 8
(No. = 172) 15.1 84.9 95.4 4.7
Total 1089 1291 2055 325
No. = 2380 45.8 54.2 86.3 13.7
*Sometimes, the sums do not add up the total due to missing values.
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We analyzed risk factors for any urinary disorders: the
results of the analysis are presented in Table 4. The risk
of any urinary symptoms increased with age: in compar-
ison with men aged < = 30 years or less the risk of any
urinary symptoms was 2.31, 2.92, 5.12, 7.82 and 17.02
respectively in the age classes 31-40, 41-50, 51-60, 61-
70 and > = 71.
Overweight/obese men were at increased risk of any uri-
nary symptoms (OR 1.35, 95% CI 1.12-1.64).
Further, any current sexual dysfunction was associated
with an increased risk of any urinary symptoms
(OR1.60. 95% CI 1.29-1.98).
Analyzing the association of overweight/obesity and any
current sexual dysfunction separately for the various uri-
nary symptoms, we observed similar results. 
Frequency and risk factors 
of sexual dysfunction
Table 5 shows the distribution of study subjects in stra-
ta of age according to the presence of sexual dysfunction
(erectile dysfunction, premature ejaculation, hypoactive
sexual desire).
27.2% (IC 95% overall 25.2% -29.3%) of the subjects
had at least a sexual disorder. The rate was 30.0% (CI
95% 18.3% -46.5%) in 30 or less, then slightly decrease
in group 31-50 and increased in older age groups, being
41,9% in the men aged > = 71 years.
The erectile dysfunction and hypoactive sexual desire
increased with age, but premature ejaculation tended to
be higher among younger aged men aged 40 years or
more.
11.9%, (44, % 95% CI 8.7% -15.8%) of men reporting
erectile dysfunction were currently treated for the condi-
tion (data not shown in Table).
We computed risk factors for sexual dysfunction sepa-
rately for premature ejaculation and erectile dysfunction. 
The results of the analysis are presented in Table 6.
The OR of premature ejaculation decreased with age
being, in comparison with men aged < = 30 years, 0.16
(95% CI 0.05-0.50) in men aged > 70 years. 
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Table 3. 
Frequency of urinary symptoms according to age.
Nocturia Dysuria Incomplete Urgency Frequency Any 
emptying symptom
N % N % N % N % N % N %
Age (years)
≤ 30 1 4 1 3 3 9
(No. = 60) 1.7 6.7 1.7 5.0 5.0 15.0
31-40 16 20 13 12 25 53
(No. = 171) 9.4 11.7 7.6 7.0 14.6 31.0
41-50 101 88 85 78 90 282
(No. = 740) 13.7 11.9 11.5 10.5 12.2 38.1
51-60 174 116 139 111 125 378
(No. = 679) 25.6 17.1 20.5 16.4 18.4 55.7
61-70 189 81 119 94 104 317
(No. = 467) 40.5 17.3 25.5 20.1 22.3 67.9
≥ 71 89 46 59 47 51 141
(No. = 172) 51.7 26.7 34.3 27.3 29.7 82.0
Total 587 375 428 350 409 1226
No. = 2380 24.7 15.8 18.1 14.7 17.2 51.5
Sometimes, the sums do not add up the total due to missing values.
Table 4. 
Odds ratios (and corresponding 95% confidence intervals)
of any urinary symptom according to selected factors.
Any urinary symptoms
No Yes OR (95CI%)
N* % N %
Age (years)
≤ 30 51 9
85.0 15.0 1°
31-40 118 53
69.0 31.0 2.31 (1.03-5.19)
41-50 458 282
61.9 38.1 2.92 (1.39-6.11)
51-60 301 378 
44.3 55.7 5.12 (2.44-10.75)
61-70 150 317 
32.1 67.9 7.82 (3.68-16.74) 
≥ 71 31 141
18.0 82.0 17.02 (7.36-39.33)
BMI (kg/m2) 
< 25.0 491 386
56.0 44.0 1°
≥ 25.0 475 636
42.8 57.3 1.35 (1.12-1.64)
Marital status
Never married 306 191
61.6 38.4 1°
Married 741 927 
44.4 55.6 1.12 (0.8-1.44)
Divorced/vidower 17 19
47.2 52.8 0.80 (0.34-1.89)
Any sexual dysfuncion
No 916 817
52.9 47.1 1°
Yes 238 409 
36.8 63.2 1.60 (1.29-1.98)
*Sometimes, the sums do not add up the total due to missing values
°Reference category
OR: odds ratio; CI: confidence interval. Multivariate estimates including terms for the
above listed variables.
Table 5. 
Frequency of sexual dysfunction according to age.
Erectile Premature Hypoactive Any sexual 
dysfunction ejaculation sexual desire dysfunction
N % N % N % N %
Age (years)
< =30 6 10 2 18 
10.0 16.7 3.3 30.0
31-40 15 20 7 30
8.8 11.79 4.1 22.8
41-50 52 55 39 127
7.0 7.4 5.3 17.2
51-60 107 46 61 184
15.8 6.8 9.0 27.1
61-70 122 35 49 181
26.1 7.5 10.5 38.8
> = 71 51 6 19 72
29.7 3.5 11.2 41.9
Total 370 178 182 647
15.6 7.5 7.7 27.2
Sometimes, the sums do not add up the total due to missing values.
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2.43)], hypertension [OR 1.66
(95%CI 1,21-2,26)] and diabetes
[OR 2.37 (95%CI 1.45-3.88)]
increased the risk of erectile dys-
function.
DISCUSSION
Before discussing the results of this
survey, potential limitations should
be considered.
The major flaw of this study is that
the study population were men vol-
untarily presenting to the
participating centers and physicians
associated to the Italian Society of
Urology (SIU). 
The participating centers were not
randomly identified among all
members, so they cannot be consid-
ered representative of all Italian
centers. However, they were well
distributed over the main areas of
the country and there were no
marked differences in the results
among centers in various large
Italian areas, giving strong support
to the consistency of the general
results. Further, the prevalence of
hypertension and diabetes and
overweight were largely similar to
the general Italian population. 
For example the percentage of over-
weight and obese men was largely
similar to that of the Italian popula-
tion (9).
Finally, the participation rate was
very high: for example the answers
to the questions about sexuality
were missing in a few number of
men. Along this line, the patients
presented voluntarily to the physi-
cian, so their answers to sensitive
questions about sexual dysfunction
should be truthful. 
The strengths of the study included
the fact that it provides information
from a large series of men identified
in all parts of Italy.
Despite the limitations, the results
of this large survey gives a general
picture of the burden of urological
conditions in the Italian popula-
tions.
Urinary symptoms
First of all In the present study the
self reported frequency of most
common low urinary tract symptoms (LUTS) was about
50%, a proportion largely similar to that reported in the
Italian centers of EPIC study. In that study nocturia was
the most prevalent LUTS (2). 
Table 6. 
Odds ratios (and corresponding 95% confidence intervals) of premature
ejaculation and erectile dysfunction according to selected factors.
Premature ejaculation Erectile dysfunction
No Yes OR (95%CI) No Yes OR (95%CI)
N* % N % N % N %
Age (years)
<=30 50 10 54 6
83.3 16.7 1° 90.0 10.0 1°
31-40 151 20 156 15
88.3 11.7 0.42 (0.16-1.08) 91.2 8.8 1.07  (0.33-3.52)
41-50 685 55 688 52
92.6 7.4 0.40 (0.18-0.88) 93.0 7.0 0.80 (0.28- 2.34)
51-60 633 46 572 107
93.2 6.8 0.34 (0.15-0.76) 84.2 15.8 1.62  (0.56-4.67)
61-70 432 35 345 122
92.5 7.5 0.38 (01.7-0.89) 73.9 26.1 2.56  (0.88-7.42)
> = 71 166 6 121 51
96.5 3.5 0.16 (0.05-0.50) 70.4 29.7 3.31  (1.10-9.95)
BMI (kg/m2) 
> = 24.9 806 71 767 110
91.9 8.1 1° 87.5 12.5 1°
> = 25.0 1027 84 895 216
92.4 7.6 0.96 (0.68-1.95) 80.6 19.4 1.25  (0.96-1.63)
Marital status
Never married 455 42 443 54
91.6 8.5 1° 89.1 10.9 1°
Married 1541 127 1377 291
92.4 7.6 1.30 (0.82-1.07) 82.6 17.5 0.84  (0.58-1.21)
Divorced/vidower 32 4 n.d. 26 10
100.0 0.0 76.0 24.0 1.71  (0.62-4.77)
Urinary symtoms
No 1069 85 1041 113
92.6 7.4 1° 90.2 9.8 1°
Yes 1133 93 969 257
92.4 7.6 1.32 (0.93-1.89) 79.0 21.0 1.85  (1.40-2.43)
Erectile dysfunction
No 1863 147
92.7 7.3 1° - - -
Yes 339 31
91.6 8.4 1.42 (0.92-2.21) - - -
Premature ejaculation
No - - - 1863 339
84.6 15.4 1°
Yes - - - 203 279
42.1 58.0 1.45  (0.94-2.23)
Hypertension
No 1909 157 1793 273
92.4 7.6 1° 86.8 13.2 1°
Yes 293 21 217 97
93.3 6.7 0.88 (0.53-1.49) 69.1 30.9 1.66  (1.21-2.26)
Diabetes
No 2119 174 1960 333
92.4 7.6 1° 85.5 14.5 1°
Yes 83 4 50 37
95.4 4.6 0.57 (0.20-1.62) 57.5 42.5 2.37  (1.45-3.88)
*Sometimes, the sums do not add up the total due to missing values
°Reference category
OR: odds ratio; CI: confidence interval. Multivariate estimates including term for the above listed variables.
Nd. Not determined.
The OR of erectile dysfunction increased with age
being, in comparison with men aged < = 30 years, 3.31
(95% CI1, 10-9.95) in men aged > 70 years. 
Current any urinary symptoms [OR 1.85 (CI 1.40-
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We confirm these findings. The frequency of urinary
symptoms increased markedly with age being about 15%
among men aged 30 years or less, but 82% among those
aged 71 or more.
This findings is consistent with other epidemiologic
studies of LUTS conducted in men, which also showed
that the prevalence of all symptoms increased linearly
with age (10, 11).
Overweight/obesity increased the risk of urinary symp-
toms. In particular overweight /obesity increased the risk
of urgency. This finding is consistent with data from
other populations (12).
Interestingly concurrent sexual dysfunction increased
the risk of urinary symptoms. 
Sexual dysfunction
This study also give further data on the frequency of the
main sexual dysfunctions in the Italian populations. 
In the present survey the reported frequency of prema-
ture ejaculation was lower than previously reported
among Italian men.
For example, the prevalence of premature ejaculation
was of about 20% in a large survey of men attending a
free andrologic consultation in about 200 Italian medical
centers, in the 2001 (13). 
This difference may be partly due to the fact that in the
2001 survey the mean age of participants was lower than
in the present study. It has been suggested that diabetes
decreased the risk of PE. 
For example a decreased risk of PE was found in men
with treated diabetes (OR 0.6, 95% CI 0.5-0.8) in men
attending a free andrologic consultation in 186 Italian
medical centers, in the setting of a project focused on
andrologic prevention in Italy (13). It is well known
that diabetic patients may develop failure of emission,
due both to neuropathic changes of the sympathetic
fibers innervating the bladder neck and to aperistalsis of
the vas deferens (14). 
These changes act in opposition to the mechanism of
PE, so that it seems diabetes gives a protective effect
against such condition In our study the estimated OR
od EP was lower than unity in men reporting diabetes,
but the finding was not statistically significant, possibly
due to the limited number of diabetics.
With regard to erectile dysfunction, the present analysis
confirm that ED is a common condition, particularly
among older men. The estimated prevalence of the con-
ditions reported in this study is largely consistent with
the findings of a population based study conducted in
Italy in the late ’90 showing a prevalence of ED of about
12% 3. Further this study confirms that diabetes, and
hyperthension increased the risk of erectile dysfunction. 
A more interesting findings id the opportunity of analyz-
ing in a large data set the association between urinary
symptoms and ED. Some recent data have in fact linked
ED risk with the presence of LUTS (15). We recorded if
men suffered from several urinary symptoms: an associ-
ation emerged between these symptoms and ED.
Finally, another interesting finding emerging from this
survey is the fact that about 85% of subjects aged > 70
year reported on or more PSA test life. This proportion
however lowered to less than 70% among men aged 51-
60 year. This finding is consistent with that reported in
other countries. For example about 60% of US men
aged 76 or older with no history of prostate cancer
reported having had a PSA test in year before the inter-
view (16). Otherwise semen analysis is uncommonly
reported: less than 15% of men reported one or more
semen analysis in life.
In conclusion, this large survey gives a picture of the
burden of the more frequent urologic conditions offering
useful information in order to focus preventive cam-
paign.
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